EXOMIND™ for Providers

Here at Reichbach Center, we’re dedicated to utilizing the most current and advanced techniques and procedures to deliver exceptional care to your patients.

Continuing that effort, we are proud to introduce EXOMIND—the newest, cutting-edge TMS (Transcranial Magnetic Stimulation) therapy.

EXOMIND allows for just 6 treatments over 3 to 6 weeks, compared to the 34+ treatments on consecutive days required by traditional TMS machines. EXOMIND is FDA-approved to treat major depressive disorder and is proven effective for anxiety, OCD, addiction, and insomnia, helping your patients sharpen focus and enhance overall cognitive well-being like never before. 

In addition to its clinical efficiency, EXOMIND produces less discomfort during treatment than other TMS machines, improving patient tolerance and continuity of care. It also maintains the same contraindications to treatment as other TMS devices, ensuring familiarity and safety for providers accustomed to existing TMS protocols.

At Reichbach Center, we go beyond symptom relief—we strive for whole-person healing. EXOMIND aligns with our philosophy of combining leading-edge medical technology with compassionate, individualized care. This revolutionary therapy is part of our growing suite of advanced services, including ketamine infusion therapy, integrative wellness protocols, and concierge-level support designed to restore balance, vitality, and clarity.